BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10396291)

  • 1. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
    Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
    Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.
    Kheterpal MK; Dai J; Geller S; Pulitzer M; Ni A; Myskowski PL; Moskowitz A; Kim J; Hong EK; Fong S; Hoppe RT; Kim YH; Horwitz SM
    J Am Acad Dermatol; 2019 Oct; 81(4):970-976. PubMed ID: 30703460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolent B-cell lymphoma with t(14;19) investigated from a molecular perspective.
    Karrs JX; Sathyanarayana SH; Xu X; Green DC; Kahn WA; Loo EY; Kaur P
    J Hematop; 2023 Dec; 16(4):217-221. PubMed ID: 38175432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade follicular lymphoma with extensive marginal zone differentiation and expression of MUM1 and CD30.
    Baykara Y; Kurt H
    Blood; 2023 Mar; 141(11):1363. PubMed ID: 36929428
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphomas and Amyloid in the Gastrointestinal Tract.
    Ware AD; Wake LM; Fedoriw Y
    Surg Pathol Clin; 2023 Dec; 16(4):719-743. PubMed ID: 37863562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive Intralymphovascular Immunoblastic Proliferations Mimicking Aggressive Lymphomas.
    Fang H; Wang W; Zhang L; Shen Q; Yuan J; Reichard KK; Hu Z; Medeiros LJ
    Am J Surg Pathol; 2022 Mar; 46(3):326-335. PubMed ID: 34310368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Apoptosis Related and Proliferative Proteins in Malignant Lympho-Proliferative Disorders.
    Jairajpuri ZS; Ghai R; Saluja S; Kapur S; Bhowmik KT
    Iran J Pathol; 2017; 12(3):231-240. PubMed ID: 29531548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.
    Cerchietti LC; Lopes EC; Yang SN; Hatzi K; Bunting KL; Tsikitas LA; Mallik A; Robles AI; Walling J; Varticovski L; Shaknovich R; Bhalla KN; Chiosis G; Melnick A
    Nat Med; 2024 May; 30(5):1503. PubMed ID: 38570701
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognosis of a Chinese patient with chronic lymphocytic leukemia who acquired a TP53 mutation following treatment with a BTK inhibitor.
    Ding YL; Li J; Yuan J; Wei Q; Li Y
    Am J Transl Res; 2023; 15(7):4813-4819. PubMed ID: 37560228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Comparative Diagnostic Features of Canine and Human Lymphoma.
    Seelig DM; Avery AC; Ehrhart EJ; Linden MA
    Vet Sci; 2016 Jun; 3(2):. PubMed ID: 28435836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
    Falini B; Fizzotti M; Pileri S; Liso A; Pasqualucci L; Flenghi L
    Ann Oncol; 1997; 8 Suppl 2():101-4. PubMed ID: 9209651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders.
    Raible MD; Hsi ED; Alkan S
    Am J Clin Pathol; 1999 Jul; 112(1):101-7. PubMed ID: 10396291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
    Jardin F; Buchonnet G; Parmentier F; Contentin N; LeprĂȘtre S; Lenain P; Picquenot JM; Laberge S; Bertrand P; Stamatoullas A; D'Anjou J; Tilly H; Bastard C
    Leukemia; 2002 Nov; 16(11):2318-25. PubMed ID: 12399978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.